Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of STON2 mRNA | CTD | PMID:20170705 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of STON2 mRNA | CTD | PMID:19167446 and PMID:21185374 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of STON2 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STON2 mRNA | CTD | PMID:20159946 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STON2 mRNA | CTD | PMID:26159488 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ston2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of STON2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of STON2 mRNA | CTD | PMID:22298810 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of STON2 mRNA | CTD | PMID:30071829 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Ston2 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of STON2 exon | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of STON2 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of STON2 mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of STON2 mRNA | CTD | PMID:32845096 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of STON2 exon | CTD | PMID:30157460 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of STON2 mRNA | CTD | PMID:32234424 | atrazine | affects methylation | ISO | Ston2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of STON2 gene | CTD | PMID:35440735 | benzo[a]pyrene | decreases methylation | ISO | Ston2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of STON2 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of STON2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of STON2 exon | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of STON2 mRNA | CTD | PMID:20170705 | bisphenol A | increases methylation | ISO | Ston2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of STON2 gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of STON2 mRNA | CTD | PMID:27685785 and PMID:33670352 | bisphenol A | affects expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of STON2 mRNA | CTD | PMID:25181051 | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of STON2 mRNA | CTD | PMID:26079696 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to STON2 gene] | CTD | PMID:28238834 | chloroprene | increases expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of STON2 mRNA | CTD | PMID:23125180 | chlorpyrifos | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of STON2 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Ston2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of STON2 mRNA | CTD | PMID:27392435 | clobetasol | decreases expression | ISO | Ston2 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of STON2 mRNA | CTD | PMID:27462272 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of STON2 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA | CTD | PMID:19167446 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA | CTD | PMID:19167446 | ethanol | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Ethanol results in increased expression of STON2 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of STON2 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Ston2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of STON2 mRNA | CTD | PMID:23649840 | L-methionine | multiple interactions | ISO | Ston2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of STON2 mRNA | CTD | PMID:19921347 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of STON2 mRNA | CTD | PMID:28988120 | maneb | multiple interactions | ISO | Ston2 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] affects the expression of STON2 mRNA | CTD | PMID:22563483 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of STON2 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of STON2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of STON2 mRNA | CTD | PMID:26272509 | oxaliplatin | multiple interactions | ISO | Ston2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of STON2 mRNA | CTD | PMID:25729387 | ozone | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Ozone results in increased expression of STON2 mRNA | CTD | PMID:31626304 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of STON2 mRNA | CTD | PMID:32845096 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of STON2 mRNA | CTD | PMID:29067470 | paraquat | multiple interactions | ISO | Ston2 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] affects the expression of STON2 mRNA | CTD | PMID:22563483 | paraquat | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | Paraquat results in increased expression of STON2 mRNA | CTD | PMID:22563483 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of STON2 mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of STON2 mRNA | CTD | PMID:25812627 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of STON2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STON2 mRNA | CTD | PMID:27188386 | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of STON2 mRNA | CTD | PMID:20816883 | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of STON2 protein | CTD | PMID:23718831 | pyridaben | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | pyridaben results in increased expression of STON2 mRNA | CTD | PMID:22563483 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of STON2 mRNA | CTD | PMID:34032870 | Soman | decreases expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of STON2 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of STON2 mRNA | CTD | PMID:31533062 | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of STON2 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | ISO | Ston2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of STON2 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Ston2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of STON2 mRNA | CTD | PMID:29264374 | topotecan | multiple interactions | ISO | Ston2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of STON2 mRNA | CTD | PMID:25729387 | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of STON2 mRNA | CTD | PMID:23228038 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of STON2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STON2 mRNA | CTD | PMID:27188386 | trifluoperazine | decreases expression | EXP | | 6480464 | Trifluoperazine analog results in decreased expression of STON2 protein | CTD | PMID:36702439 | trifluoperazine | multiple interactions | EXP | | 6480464 | STON2 protein inhibits the reaction [Trifluoperazine analog results in decreased phosphorylation of MTOR protein] | CTD | PMID:36702439 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of STON2 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of STON2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects splicing | ISO | Ston2 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of STON2 mRNA | CTD | PMID:29427782 | vinclozolin | decreases methylation | ISO | Ston2 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased methylation of STON2 gene | CTD | PMID:30207508 | |